Literature DB >> 3566321

Forehead plaque: a presenting skin sign in tuberous sclerosis.

A E Fryer, J P Osborne, W Schutt.   

Abstract

The forehead plaque can be the earliest skin manifestation of tuberous sclerosis and its presence may lead to early diagnosis and appropriate genetic counselling.

Entities:  

Mesh：

Year:  1987        PMID： 3566321      PMCID： PMC1778289          DOI： 10.1136/adc.62.3.292

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  5 in total

1.  Tuberous sclerosis. Special reference to the microscopic alterations in the cutaneous hamartomas.

Authors:  W R NICKEL; W B REED
Journal:  Arch Dermatol       Date:  1962-02

2.  The late appearance of hypopigmented maculae in tuberous sclerosis.

Authors:  E Y Oppenheimer; N P Rosman; E C Dooling
Journal:  Am J Dis Child       Date:  1985-04

3.  Depigmented hair. The earliest sign of tuberous sclerosis.

Authors:  R C McWilliam; J B Stephenson
Journal:  Arch Dis Child       Date:  1978-12       Impact factor: 3.791

4.  The incidence and significance of birthmarks in a cohort of 4,641 newborns.

Authors:  J C Alper; L B Holmes
Journal:  Pediatr Dermatol       Date:  1983-07       Impact factor: 1.588

5.  DEPIGMENTED NEVI: THE EARLIEST SIGN OF TUBEROUS SCLEROSIS.

Authors:  A P GOLD; J M FREEMAN
Journal:  Pediatrics       Date:  1965-06       Impact factor: 7.124
  5 in total
  3 in total

Review 1.  Diagnosis of tuberous sclerosis.

Authors:  J P Osborne
Journal:  Arch Dis Child       Date:  1988-12       Impact factor: 3.791

2.  Diagnostic and counselling difficulties using a fully comprehensive screening protocol for families at risk for tuberous sclerosis.

Authors:  L I al-Gazali; R J Arthur; J T Lamb; H M Hammer; T P Coker; P N Hirschmann; J Gibbs; R F Mueller
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

3.  Subependymal giant cell astrocytoma: a report of five cases.

Authors:  Raj Kumar; Vinita Singh
Journal:  Neurosurg Rev       Date:  2004-08-12       Impact factor: 3.042
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.